{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:10:37Z","timestamp":1767474637128,"version":"3.48.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To comprehensively integrate current evidence on the molecular mechanisms, diagnostic approaches, and treatment options for primary pancreatic signet ring cell carcinoma (PPSRCC), guiding clinical decision-making and improving prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In addition to the narrative synthesis, we performed a targeted extraction and comparative synthesis of published patient-level cases, case series, and registry studies to generate pooled clinicopathologic summaries, propose an operational diagnostic workflow (imaging\u2013EUS-FNA\u2013IHC\u2013molecular testing), and formulate PPSRCC-specific management recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Primary pancreatic signet ring cell carcinoma (PPSRCC) is a rare pancreatic cancer subtype with extremely high malignancy and very poor prognosis. Current research on this disease is limited with weak evidence, leading to insufficient clinical awareness. PPSRCC exhibits unique epidemiological characteristics, molecular mechanisms, and clinical diagnostic and therapeutic features. Molecular studies suggest that its carcinogenic pathways involve abnormal activation of the ErbB2\/ErbB3-MUC4 axis, activation of the PI3K and MAPK pathways, and frequent mutations in classical pancreatic cancer driver genes such as KRAS; however, the lack of specific molecular biomarkers and typical imaging findings makes clinical diagnosis challenging. In terms of treatment, clinical practice mostly refers to the therapeutic strategies for pancreatic ductal adenocarcinoma (PDAC), primarily surgery combined with radiochemotherapy. Targeted therapies against KRAS mutations and immunotherapy targeting PD-L1 may provide new directions for future management. In-depth elucidation of the molecular features of PPSRCC, clarification of diagnostic and therapeutic strategies, and development of novel targeted agents are key to improving clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Deeper mechanistic interrogation and standardized diagnostic workflows are needed to enable earlier detection and tailored therapy in PPSRCC. Multidisciplinary care and emerging precision strategies may improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04106-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:15:04Z","timestamp":1764220504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary pancreatic signet ring cell carcinoma: molecular mechanisms and advances in clinical diagnosis and treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianping","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"6","key":"4106_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/MPA.0000000000001338","volume":"48","author":"G Luo","year":"2019","unstructured":"Luo G, Fan Z, Gong Y, Jin K, Yang C, Cheng H, et al. Characteristics and outcomes of pancreatic cancer by histological subtypes. Pancreas. 2019;48(6):817\u201322.","journal-title":"Pancreas"},{"issue":"1","key":"4106_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12876-023-02650-5","volume":"23","author":"D Nie","year":"2023","unstructured":"Nie D, Yang J, Zheng H, Lai G, Wang F, Cao J, et al. Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database. BMC Gastroenterol. 2023;23(1):62.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"4106_CR3","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/ccr3.2475","volume":"7","author":"D Alexander","year":"2019","unstructured":"Alexander D, Rashid L, Hollis M, Kavuturu S. Primary signet ring cell carcinoma of the pancreatic head: a case report. Clin Case Rep. 2019;7(11):2235\u20138.","journal-title":"Clin Case Rep"},{"issue":"1","key":"4106_CR4","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4106_CR5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4300\/JGME-D-22-00480.1","volume":"14","author":"J Sukhera","year":"2022","unstructured":"Sukhera J. Narrative reviews: flexible, rigorous, and practical. J Grad Med Educ. 2022;14(4):414\u20137.","journal-title":"J Grad Med Educ"},{"key":"4106_CR6","doi-asserted-by":"crossref","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","DOI":"10.1111\/his.13975"},{"issue":"43","key":"4106_CR7","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.3748\/wjg.v17.i43.4757","volume":"17","author":"NK Lee","year":"2011","unstructured":"Lee NK, Kim S, Kim HS, Jeon TY, Kim GH, Kim DU, et al. Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation. World J Gastroenterol. 2011;17(43):4757\u201371.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"4106_CR8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/COC.0000000000000447","volume":"41","author":"M Patel","year":"2018","unstructured":"Patel M, Hans HS, Pan K, Khan H, Donath E, Caldera H. The impact of epidemiological factors and treatment interventions on survival in patients with signet ring cell carcinoma of the pancreas. Am J Clin Oncol. 2018;41(12):1176\u201384.","journal-title":"Am J Clin Oncol"},{"key":"4106_CR9","doi-asserted-by":"crossref","first-page":"1205594","DOI":"10.3389\/fendo.2023.1205594","volume":"14","author":"H Zhou","year":"2023","unstructured":"Zhou H, Li XX, Huang YP, Wang YX, Zou H, Xiong L, et al. Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study. Front Endocrinol (Lausanne). 2023;14:1205594.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4106_CR10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12876-022-02543-z","volume":"22","author":"D Nie","year":"2022","unstructured":"Nie D, Lan Q, Huang Y, Fang C, Cao Y, Chen Y. Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study. BMC Gastroenterol. 2022;22(1):458.","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"4106_CR11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/dc.24324","volume":"47","author":"S El Hussein","year":"2019","unstructured":"El Hussein S, Khader SN. Primary signet ring cell carcinoma of the pancreas: cytopathology review of a rare entity. Diagn Cytopathol. 2019;47(12):1314\u201320.","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"4106_CR12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbrc.2014.07.025","volume":"450","author":"Y Fukui","year":"2014","unstructured":"Fukui Y. Mechanisms behind signet ring cell carcinoma formation. Biochem Biophys Res Commun. 2014;450(4):1231\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"4106_CR13","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100251","volume":"36","author":"M Simbolo","year":"2023","unstructured":"Simbolo M, Silvestris N, Malleo G, Mafficini A, Maggino L, Cocomazzi A, et al. Clinical and genomic characterization of pancreatic ductal adenocarcinoma with signet-ring\/poorly cohesive cells. Mod Pathol. 2023;36(9):100251.","journal-title":"Mod Pathol"},{"issue":"4","key":"4106_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc.2017.5","volume":"17","author":"G Schneider","year":"2017","unstructured":"Schneider G, Schmidt-Supprian M, Rad R, Saur D. Tissue-specific tumorigenesis: context matters. Nat Rev Cancer. 2017;17(4):239\u201353.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4106_CR15","first-page":"1006","volume":"38","author":"General Office of National Health Commission","year":"2022","unstructured":"General Office of National Health Commission. Standard for diagnosis and treatment of pancreatic cancer (2022 edition). J Clin Hepatol. 2022;38(5):1006\u201315.","journal-title":"J Clin Hepatol"},{"issue":"12","key":"4106_CR16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.hpb.2020.03.024","volume":"22","author":"CJ Kinslow","year":"2020","unstructured":"Kinslow CJ, May MS, Kozak M, Pollom EL, Chang DT. Signet ring cell carcinoma of the ampulla of Vater: outcomes of patients in the united States. HPB (Oxford). 2020;22(12):1759\u201365.","journal-title":"HPB (Oxford)"},{"key":"4106_CR17","doi-asserted-by":"crossref","first-page":"101747","DOI":"10.1016\/j.eclinm.2022.101747","volume":"55","author":"LNC Boyd","year":"2022","unstructured":"Boyd LNC, Ali M, Leeflang MMG, Treglia G, de Vries R, Le Large TYS, et al. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data. EClinicalMedicine. 2022;55:101747.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4106_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/pancan.2020.0013","volume":"7","author":"DJ Campbell","year":"2021","unstructured":"Campbell DJ, Isch EL, Kozak GM, Yeo CJ. Primary pancreatic signet ring cell carcinoma: a case report and review of the literature. J Pancreat Cancer. 2021;7(1):1\u20137.","journal-title":"J Pancreat Cancer"},{"issue":"28","key":"4106_CR19","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","volume":"40","author":"M Dbouk","year":"2022","unstructured":"Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, et al. The Multicenter Cancer of Pancreas Screening Study: impact on stage and survival. J Clin Oncol. 2022;40(28):3257\u201366.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4106_CR20","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjy218","volume":"2018","author":"N Yepuri","year":"2018","unstructured":"Yepuri N, Naous R, Richards C, Dhir M, Jain A. Poorly differentiated signet ring cell carcinoma of pancreas masquerading as chronic pancreatitis. J Surg Case Rep. 2018;2018(8):rjy218.","journal-title":"J Surg Case Rep"},{"issue":"1","key":"4106_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jmri.27056","volume":"53","author":"M Alabousi","year":"2021","unstructured":"Alabousi M, McInnes MD, Salameh JP, Satkunasingham J, Kagoma YK, Ruo L, et al. MRI vs. CT for detection of liver metastases in patients with pancreatic carcinoma: A comparative diagnostic test accuracy meta-analysis. J Magn Reson Imaging. 2021;53(1):38\u201348.","journal-title":"J Magn Reson Imaging"},{"issue":"19","key":"4106_CR22","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/diagnostics13193123","volume":"13","author":"M Tachibana","year":"2023","unstructured":"Tachibana M, Hirota T, Hamayasu H, Takeuchi Y, Tsukamoto K, Matsushita M. Colloid carcinoma arising in an intestinal-type IPMN with high-grade dysplasia appearing as signet-ring cells of the pancreas by serial pancreatic juice aspiration cytology: a case report. Diagnostics (Basel). 2023;13(19):3123.","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"4106_CR23","first-page":"666","volume":"60","author":"JA Li","year":"2022","unstructured":"Li JA, Xu YL, Ding N, Ji Y, Liu LX, Rao SX, et al. Pancreas multidisciplinary team optimizes diagnosis\/treatment and improves prognosis of pancreatic cancer patients. Chin J Surg. 2022;60(7):666\u201373.","journal-title":"Chin J Surg"},{"issue":"7","key":"4106_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","volume":"5","author":"SP Pereira","year":"2020","unstructured":"Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020;5(7):698\u2013710.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"4106_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmayr C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500\u201310.","journal-title":"Nat Rev Cancer"},{"issue":"7639","key":"4106_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115\u20138.","journal-title":"Nature"},{"key":"4106_CR27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He X, Liu X, Zuo F, Shi H, Jing J. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol. 2023;88:187\u2013200.","journal-title":"Semin Cancer Biol"},{"key":"4106_CR28","doi-asserted-by":"crossref","first-page":"104888","DOI":"10.1016\/j.ebiom.2023.104888","volume":"98","author":"K Jia","year":"2023","unstructured":"Jia K, Kundrot S, Palchuk MB, Warnick J, Haapala K, Kaplan ID, et al. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. EBioMedicine. 2023;98:104888.","journal-title":"EBioMedicine"},{"issue":"5","key":"4106_CR29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","volume":"29","author":"D Placido","year":"2023","unstructured":"Placido D, Yuan B, Hjaltelin JX, Zheng C, Haue AD, Chmura PJ, et al. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023;29(5):1113\u201322.","journal-title":"Nat Med"},{"issue":"6","key":"4106_CR30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00428-010-0978-5","volume":"457","author":"N Dursun","year":"2010","unstructured":"Dursun N, Feng J, Basturk O, Bandyopadhyay S, Cheng JD, Adsay VN. Vacuolated cell pattern of pancreatobiliary adenocarcinoma: a clinicopathological analysis of 24 cases. Virchows Arch. 2010;457(6):643\u20139.","journal-title":"Virchows Arch"},{"key":"4106_CR31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.5858\/2006-130-799-MPISCC","volume":"130","author":"MD Nguyen","year":"2006","unstructured":"Nguyen MD, Plasil B, Wen P, Frankel WL. Mucin profiles in signet-ring cell carcinoma. Arch Pathol Lab Med. 2006;130:799\u2013804.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"4106_CR32","doi-asserted-by":"crossref","first-page":"omaf072","DOI":"10.1093\/omcr\/omaf072","volume":"2025","author":"C Zeta-Arica","year":"2025","unstructured":"Zeta-Arica C, Galarreta-Galvez L, Revoredo-Rego F, Kometter-Barrios F, Arenas-Gamio J. Signet ring cell carcinoma of the ampulla of vater: case series. Oxf Med Case Rep. 2025;2025(6):omaf072.","journal-title":"Oxf Med Case Rep"},{"issue":"7","key":"4106_CR33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","volume":"21","author":"EG Chiorean","year":"2023","unstructured":"Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, et al. Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(7):753\u201382.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"4106_CR34","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3892\/ol.2014.2344","volume":"8","author":"X Wen","year":"2014","unstructured":"Wen X, Wu W, Wang B, Yao H, Teng X. Signet ring cell carcinoma of the ampulla of Vater: immunophenotype and differentiation. Oncol Lett. 2014;8(4):1687\u201392.","journal-title":"Oncol Lett"},{"issue":"S2","key":"4106_CR35","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1055\/s-0030-1257045","volume":"44","author":"T Terada","year":"2012","unstructured":"Terada T. Primary signet-ring cell carcinoma of the pancreas diagnosed by ERCP duct biopsy: a case with IHC study. Endoscopy. 2012;44(S2):E141\u20132.","journal-title":"Endoscopy"},{"issue":"4","key":"4106_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12029-015-9763-7","volume":"46","author":"F Karaa hmet","year":"2015","unstructured":"Karaa hmet F, Basar O, Coban S, Aydo\u011f G, Yuksel O. Signet ring cell carcinoma of both colon and pancreas. J Gastrointest Cancer. 2015;46(4):445\u20136.","journal-title":"J Gastrointest Cancer"},{"issue":"11","key":"4106_CR37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"issue":"1","key":"4106_CR38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hpb.2022.08.004","volume":"25","author":"A Takahashi","year":"2023","unstructured":"Takahashi A, Mise Y, Watanabe G, Yoshioka R, Ono Y, Inoue Y, et al. Radical antegrade modular pancreatosplenectomy enhances local control in left-sided pancreatic cancer. HPB (Oxford). 2023;25(1):37\u201344.","journal-title":"HPB (Oxford)"},{"key":"4106_CR39","unstructured":"National Comprehensive Cancer Network (NCCN). Pancreatic Adenocarcinoma, Version 1.2025."},{"issue":"4","key":"4106_CR40","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1245\/s10434-023-14650-6","volume":"31","author":"TF Stoop","year":"2024","unstructured":"Stoop TF, Seelen LWF, van\u2019t Land FR, Lutchman KRD, van Dieren S, Lips DJ, et al. Nationwide surgery for locally advanced pancreatic cancer following induction chemotherapy. Ann Surg Oncol. 2024;31(4):2640\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4106_CR41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1148\/radiol.2019190422","volume":"293","author":"I Joo","year":"2019","unstructured":"Joo I, Lee JM, Lee ES, Son JY, Lee DH, Ahn SJ, et al. Preoperative CT classification of pancreatic cancer resectability: interobserver agreement. Radiology. 2019;293(2):343\u20139.","journal-title":"Radiology"},{"issue":"5","key":"4106_CR42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2007.12.020","volume":"206","author":"MH Katz","year":"2008","unstructured":"Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al. Borderline resectable pancreatic cancer: importance of this emerging stage. J Am Coll Surg. 2008;206(5):833\u201346.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"4106_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/SLA.0000000000003859","volume":"275","author":"A Oba","year":"2022","unstructured":"Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, et al. Prognosis based definition of resectability in pancreatic cancer: A road map to new guidelines. Ann Surg. 2022;275(1):175\u201381.","journal-title":"Ann Surg"},{"issue":"12","key":"4106_CR44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.23.01311","volume":"42","author":"EN Dekker","year":"2024","unstructured":"Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, et al. Improved clinical staging system using ABC factors. J Clin Oncol. 2024;42(12):1357\u201367.","journal-title":"J Clin Oncol"},{"issue":"7","key":"4106_CR45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jhbp.1049","volume":"29","author":"A Oba","year":"2022","unstructured":"Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, et al. New criteria of resectability for pancreatic cancer: a position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). J Hepatobiliary Pancreat Sci. 2022;29(7):725\u201331.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"4106_CR46","doi-asserted-by":"crossref","first-page":"e0302685","DOI":"10.1371\/journal.pone.0302685","volume":"19","author":"K Huang","year":"2024","unstructured":"Huang K, Yuan X, Zhao P, Yunshen. He. Effect of chemotherapy on prognosis in primary pancreatic SRCC: a real-world study based on machine learning. PLoS ONE. 2024;19(5):e0302685.","journal-title":"PLoS ONE"},{"issue":"2","key":"4106_CR47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/JP9.0000000000000094","volume":"5","author":"R Chao","year":"2022","unstructured":"Chao R, Feng X, Yin YW. Lymph node ratio and total lymph nodes examined in resected pancreatic SRCC: a retrospective cohort study. J Pancreatology. 2022;5(2):87\u201395.","journal-title":"J Pancreatology"},{"issue":"Suppl 1","key":"4106_CR48","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.5301\/TJ.5000671","volume":"103","author":"M Radojkovic","year":"2017","unstructured":"Radojkovic M, Ilic D, Ilic I. Primary pancreatic SRCC with good response to chemotherapy: case report and literature review. Tumori. 2017;103(Suppl 1):e50\u20132.","journal-title":"Tumori"},{"issue":"3","key":"4106_CR49","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12328-023-01783-0","volume":"16","author":"M Nakamura","year":"2023","unstructured":"Nakamura M, Inagaki F, Takemura N, Yoshizaki Y, Ito K, Mihara F, et al. Multivisceral resection for primary pancreatic SRCC. Clin J Gastroenterol. 2023;16(3):482\u20137.","journal-title":"Clin J Gastroenterol"},{"issue":"06","key":"4106_CR50","first-page":"713","volume":"46","author":"J Zhang","year":"2025","unstructured":"Zhang J, Huang H, Tang B, Li H, Zhang X, Qu QP. Pancreatic body adenocarcinoma with concomitant tail SRCC: a case report. Sichuan Med J. 2025;46(06):713\u20136.","journal-title":"Sichuan Med J"},{"issue":"23","key":"4106_CR51","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1200\/JCO.2013.53.6995","volume":"32","author":"H Oettle","year":"2014","unstructured":"Oettle H, Riess H, Stieler JM, Heil G, Schwaner I, Seraphin J, et al. Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial. J Clin Oncol. 2014;32(23):2423\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4106_CR52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.suc.2017.09.008","volume":"98","author":"E Landau","year":"2018","unstructured":"Landau E, Kalnicki S. The evolving role of radiation in pancreatic cancer. Surg Clin North Am. 2018;98(1):113\u201325.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"4106_CR53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imr.12573","volume":"280","author":"N Brix","year":"2017","unstructured":"Brix N, Tiefenthaller A, Anders H, Belka C, Lauber K. Abscopal, immunological effects of radiotherapy: narrowing the gap between clinical and preclinical experiences. Immunol Rev. 2017;280(1):249\u201379.","journal-title":"Immunol Rev"},{"issue":"10","key":"4106_CR54","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1158\/1078-0432.CCR-22-1108","volume":"28","author":"GD Demetri","year":"2022","unstructured":"Demetri GD, De Braud F, Drilon A, Siena S, Patel MR, Cho BC, et al. Correction: Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK Fusion-Positive solid tumors. Clin Cancer Res. 2022;28(10):2196.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4106_CR55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 2020;21(4):531\u201340.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4106_CR56","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","volume":"65","author":"X Wang","year":"2022","unstructured":"Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, et al. Identification of MRTX1133, a Noncovalent, Potent, and selective KRASG12D inhibitor. J Med Chem. 2022;65(4):3123\u201333.","journal-title":"J Med Chem"},{"issue":"7968","key":"4106_CR57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","volume":"619","author":"D Kim","year":"2023","unstructured":"Kim D, Herdeis L, Rudolph D, Zhao Y, B\u00f6ttcher J, Vides A, et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature. 2023;619(7968):160\u20136.","journal-title":"Nature"},{"key":"4106_CR58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.25259\/Cytojournal_2_2025","volume":"22","author":"C Canbey","year":"2025","unstructured":"Canbey C, \u015een S, Karabulut S, \u00d6zcan TB, Pa\u015fao\u011flu E, Altun E, et al. Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer? Cytojournal. 2025;22:47.","journal-title":"Cytojournal"},{"issue":"2","key":"4106_CR59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17474124.2018.1416291","volume":"12","author":"SG Wu","year":"2018","unstructured":"Wu SG, Chen XT, Zhang WW, Sun JY, Li FY, He ZY, et al. Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis. Expert Rev Gastroenterol Hepatol. 2018;12(2):209\u201314.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4106_CR60","first-page":"S2239253X200344","volume":"9","author":"A Caranti","year":"2020","unstructured":"Caranti A, Budini M, Mangano M, Cirstaudi A, Demagistri D. Primary signet ring cell carcinoma of the pancreas A case report about an extremely rare variant of pancreatic carcinoma. Ann Ital Chir. 2020;9:S2239253X2003443X.","journal-title":"Ann Ital Chir"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04106-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:04:35Z","timestamp":1767474275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04106-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4106"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04106-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}